High-risk MS therapy gives trial subjects 'last shot at living'

dr. freedman dr. atkins ms research ottawa hospital

New Canadian research led by two Ottawa doctors and published in The Lancet medical journal on Thursday suggests a high-risk therapy may stop multiple sclerosis from progressing, and even reverse the disease.



from CBC | Health News http://ift.tt/24E11Mw

Aucun commentaire:

Enregistrer un commentaire